Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments-Reference-Cited by-同舟云学术

Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments

Published:2018-11-16 Issue:2 Volume:22 Page:119-135
ISSN:1461-1457
Container-title:International Journal of Neuropsychopharmacology
language:en
Short-container-title:

Author:

Kadriu Bashkim¹,Musazzi Laura²,Henter Ioline D¹,Graves Morgan¹,Popoli Maurizio²,Zarate Carlos A¹

Affiliation:

1. Section on the Neurobiology and Treatment of Mood Disorders, Intramural Research Program, National Institute of Mental Health, Bethesda, MD

2. Laboratory of Neuropsychopharmacology and Functional Neurogenomics – Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases, University of Milano, Milan, Italy

Funder

National Institute of Mental Health

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology

Link

http://academic.oup.com/ijnp/article-pdf/22/2/119/27738690/pyy094.pdf

Reference187 articles.

1. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression;Aan het Rot;Biol Psychiatry,2010

2. Ketamine for depression: where do we go from here;Aan Het Rot;Biol Psychiatry,2012

3. Prefrontal connectivity and glutamate transmission: relevance to depression pathophysiology and ketamine treatment;Abdallah;Biol Psychiatry Cogn Neurosci Neuroimaging,2017

4. Ketamine treatment and global brain connectivity in major depression;Abdallah;Neuropsychopharmacology,2017

5. The neurobiology of depression, ketamine and rapid-acting antidepressants: is it glutamate inhibition or activation;Abdallah;Pharmacol Ther,2018

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review;European Neuropsychopharmacology;2024-09

2. Advancing past ketamine: emerging glutamatergic compounds for the treatment of depression;European Archives of Psychiatry and Clinical Neuroscience;2024-08-29

3. Glutamatergic Modulators for Major Depression from Theory to Clinical Use;CNS Drugs;2024-08-16

4. Ghrelin, Neuroinflammation, Oxidative Stress, and Mood Disorders: What Are the Connections?;Current Neuropharmacology;2024-07-22

5. Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders;International Journal of Molecular Sciences;2024-06-13